204 related articles for article (PubMed ID: 17881980)
1. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management.
Levy EI; Turk AS; Albuquerque FC; Niemann DB; Aagaard-Kienitz B; Pride L; Purdy P; Welch B; Woo H; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella DJ
Neurosurgery; 2007 Sep; 61(3):644-50; discussion 650-1. PubMed ID: 17881980
[TBL] [Abstract][Full Text] [Related]
2. Angiographic patterns of Wingspan in-stent restenosis.
Albuquerque FC; Levy EI; Turk AS; Niemann DB; Aagaard-Kienitz B; Pride GL; Purdy PD; Welch BG; Woo HH; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella DJ
Neurosurgery; 2008 Jul; 63(1):23-7; discussion 27-8. PubMed ID: 18728565
[TBL] [Abstract][Full Text] [Related]
3. [Predictors of Wingspan in-stent restenosis for the treatment of symptomatic intracranial arterial stenosis].
Ma MM; Yin Q; Xu GL; Zhang RL; Zhu SG; Fan XY; Zhu WS; Liu XF
Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1303-7. PubMed ID: 21756754
[TBL] [Abstract][Full Text] [Related]
4. Neuroform in-stent stenosis: incidence, natural history, and treatment strategies.
Fiorella D; Albuquerque FC; Woo H; Rasmussen PA; Masaryk TJ; McDougall CG
Neurosurgery; 2006 Jul; 59(1):34-42; discussion 34-42. PubMed ID: 16823298
[TBL] [Abstract][Full Text] [Related]
5. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
[TBL] [Abstract][Full Text] [Related]
6. Five-year clinical follow up after intracoronary radiation for the prevention of in-stent restenosis.
Gruberg L; Caiati R; Aronson D; Suleiman M; Petchersky S; Nikolsky E; Grenadier E; Boulus M; Markiewicz W; Kerner A; Beyar R
J Invasive Cardiol; 2006 Oct; 18(10):494-8. PubMed ID: 17042094
[TBL] [Abstract][Full Text] [Related]
7. Target lesion revascularization after wingspan: assessment of safety and durability.
Fiorella DJ; Levy EI; Turk AS; Albuquerque FC; Pride GL; Woo HH; Welch BG; Niemann DB; Purdy PD; Aagaard-Kienitz B; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG
Stroke; 2009 Jan; 40(1):106-10. PubMed ID: 18927447
[TBL] [Abstract][Full Text] [Related]
8. Everolimus- and zotarolimus-eluting stents for bare metal stent in-stent restenosis treatment: a prospective study.
Toutouzas K; Patsa C; Tsiamis E; Tsioufis C; Spanos A; Stefanadi E; Tentolouris C; Stefanadis C
J Interv Cardiol; 2008 Oct; 21(5):388-94. PubMed ID: 18705639
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
10. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
11. Vascular brachytherapy for patients with drug-eluting stent restenosis.
Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
[TBL] [Abstract][Full Text] [Related]
13. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.
Fiorella D; Chow MM; Anderson M; Woo H; Rasmussen PA; Masaryk TJ
Neurosurgery; 2007 Aug; 61(2):236-42; discussion 242-3. PubMed ID: 17762735
[TBL] [Abstract][Full Text] [Related]
14. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Ellis SG; O'Shaughnessy CD; Martin SL; Kent K; McGarry T; Turco MA; Kereiakes DJ; Popma JJ; Friedman M; Koglin J; Stone GW;
Eur Heart J; 2008 Jul; 29(13):1625-34. PubMed ID: 18556716
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
[TBL] [Abstract][Full Text] [Related]
16. Influence of patient age and stenosis location on wingspan in-stent restenosis.
Turk AS; Levy EI; Albuquerque FC; Pride GL; Woo H; Welch BG; Niemann DB; Purdy PD; Aagaard-Kienitz B; Rasmussen PA; Hopkins LN; Masaryk TJ; McDougall CG; Fiorella D
AJNR Am J Neuroradiol; 2008 Jan; 29(1):23-7. PubMed ID: 17989366
[TBL] [Abstract][Full Text] [Related]
17. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
18. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry.
Daemen J; Kukreja N; van Twisk PH; Onuma Y; de Jaegere PP; van Domburg R; Serruys PW
Am J Cardiol; 2008 Apr; 101(8):1105-11. PubMed ID: 18394442
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
20. Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry).
Yan BP; Duffy SJ; Clark DJ; Lefkovits J; Warren R; Gurvitch R; Lew R; Sebastian M; Brennan A; Andrianopoulos N; Reid CM; Ajani AE;
Am J Cardiol; 2008 Jun; 101(12):1716-22. PubMed ID: 18549846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
